Raise Growth Capital

In the ever-changing industry landscape – financial meltdowns, governmental pressures, juxtaposed with the current situation of declining revenues and profits, owing to a variety of reasons (patent expiries, pressures on prices, restructuring, strategic shifts etc., many pharmaceutical and biotech companies world over are facing the crunch for expansion capital & growth equity to fuel their growth plans. Also with companies aiming for quick-wins, promising technologies, new products and newer drug delivery platforms, the need for a capital source to fund these opportunities was never more acute. Garphi, along with its associates engages with clients selectively to raise capital to fund their growth strategies. We work closely with clients to understand, whether the company is poised and prepared for taking the leap for growth, together with the identified Equity Partner. Garphi deploys the collective and complimentary expertise and capabilities of its core team to identify and develop opportunities for each client and chart out the success roadmap. Garphi leverages on its rich network of relationships in the industry, to reach out and identify the most appropriate partner for capital raising depending upon the opportunities, growth plans, the capital size, the risk appetite etc. The entire capital syndication process is managed by Garphi and its associates in confidence with the Equity Partners. Garphi advises its clients on its growth capital services for

• Infusing Growth/Expansionary Capital

• Facilitating Acquisition Financing

• Special Situations/Restructuring

Be it for, expansion or restructure of current operations or enter new markets or just finance an acquisition for faster growth, to advise and take you through, all your growth strategies give us a call at +91 40 4003 1534 or write to us at info@garphi.com